Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in EDSA — Edesa Biotech, Inc.

CIK 1214717 BOSTON, MA
Back to EDSA Full portfolio

Position in EDSA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$657,545
+$254,554 QoQ
Shares Held
80,879
+5.0% QoQ
Ownership
0.839%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 33 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. EDSA ranks #347 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in EDSA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $657,545 80,879
2026-03-31 $402,991 77,054
2025-12-31 $66,081 46,537
2025-09-30 $111,727 45,234
2025-06-30 $56,749 27,956
2025-03-31 $70,686 28,970
2024-12-31 $33,270 19,804
2024-09-30 $92,599 20,809
2024-06-30 $77,976 18,219
2024-03-31 $60,273 14,385
2023-12-31 $67,087 14,680
2023-09-30 $64,757 102,790
2023-06-30 $70,223 86,696
2023-03-31 $78,893 86,696
2022-12-31 $187,263 86,696
2022-09-30 $75,852 82,448
2022-06-30 $132,741 82,448
2022-03-31 $238,398 80,269
2021-12-31 $434,911 77,249
2021-09-30 $570,097 77,249
2021-06-30 $390,888 74,032
2021-03-31 $157,836 29,229